Global Constipation Treatment Market Forecast Highlighting Expansion And Competitive Dynamics

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Much Larger Will The Constipation Treatment Market Become By 2030 Compared To 2026?

The constipation treatment market has seen substantial growth over recent years. It is forecast to increase from $12.71 billion in 2025 to $13.75 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 8.2%. This historical expansion can be linked to the high prevalence of gastrointestinal disorders, sedentary lifestyle patterns, dietary fiber deficiency, reliance on traditional laxatives, and the growth of the aging population.

The constipation treatment market is projected for significant expansion over the coming years, anticipated to reach $18.72 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 8.0%. This anticipated growth is largely driven by factors such as an increase in chronic constipation diagnoses, elevated opioid consumption, a heightened focus on gut health, the expansion of specialized gastroenterology services, and better availability of new therapeutic options. Key trends expected during this period involve a surge in prescribed treatments for chronic constipation, greater uptake of probiotics and related gut health items, a move towards drugs with specific mechanisms of action, an intensified effort in managing opioid-induced constipation, and the broadening reach of online pharmacy distribution.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12134&type=smp

Which Major Factors Are Contributing To The Development Of The Constipation Treatment Market?

An anticipated surge in gastrointestinal disorders is set to propel the expansion of the constipation treatment market in the foreseeable future. Digestive disorders, also known as gastrointestinal disorders, cover a variety of ailments impacting the digestive tract, and constipation frequently manifests as a symptom of many of these conditions. The rising occurrence of gastrointestinal disorders, such as irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD), stimulates the growth of the constipation treatment market because these ailments often present with constipation, leading to a greater demand for targeted and efficacious treatments amidst increasing understanding. For example, the American Cancer Society, a non-profit organization located in the U.S., projected in January 2024 that around 26,890 new instances of stomach cancer would be expected in the U.S. in 2024, with 16,160 cases among men and 10,730 among women. This form of cancer is also expected to result in approximately 10,880 fatalities, split between 6,490 men and 4,390 women. Consequently, the increasing prevalence of gastrointestinal disorders is a key factor driving the growth of the constipation treatment market.

Which Segment Groups Define The Constipation Treatment Market Landscape?

The constipation treatment market covered in this report is segmented –

1) By Therapeutic Types: Laxatives, Chloride Channel Activators, Peripherally Acting Mu-Opioid Receptor Antagonists, Guanylate Cyclase-C (GC-C) Agonists, Other Therapeutics

2) By Disease Type: Chronic Idiopathic Constipation (CIC), Irritable Bowel Syndrome With Constipation (IBS-C), Opioid-Induced Constipation (OIC)

3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Laxatives: Bulk-Forming Laxatives, Osmotic Laxatives, Stimulant Laxatives, Stool Softeners

2) By Chloride Channel Activators: Lubiprostone-Based Formulations, Other Chloride Channel Activators

3) By Peripherally Acting Mu-Opioid Receptor Antagonists: Methylnaltrexone Formulations, Naloxegol Formulations, Other PAMORAs

4) By Guanylate Cyclase-C (GC-C) Agonists: Linaclotide Formulations, Plecanatide Formulations, Other GC-C Agonists

5) By Other Therapeutics: Prokinetic Agents, Serotonin 5-HT4 Receptor Agonists, Herbal and Alternative Formulations

What Trends Are Influencing The Future Of The Constipation Treatment Market?

Leading companies in the constipation treatment market are concentrating on creating novel remedies, such as drug-free mechanical stimulation capsules (vibrating capsules). This effort aims to satisfy the increasing need for efficacious therapies that minimize side effects, a demand fueled by an aging demographic, increased opioid consumption, and patients’ preference for non-pharmacological approaches. Such a vibrating capsule is a single-use oral device designed for swallowing. It encases a miniature vibration motor and battery within a medical-grade, excretable shell. Its purpose is to mechanically stimulate the colon at predetermined intervals, thereby inducing peristalsis and providing predictable bowel movements without the systemic impacts typically associated with laxatives or prescription prokinetics. As an illustration, in May 2023, Vibrant Ltd., a medical technology firm based in the US, introduced Vibrant. This prescription-only vibrating capsule system received clearance from the U.S. Food and Drug Administration (FDA) for use by adults suffering from chronic idiopathic constipation who have shown no improvement with laxatives. The system comprises a reusable activation pod and a single-use capsule. This capsule contains a coin-sized vibration motor, an electronic control card, and batteries, all contained within a two-piece shell. The pod is responsible for programming the capsule, which subsequently delivers a sequence of brief vibration cycles, specifically around 190 cycles per hour, featuring timed bursts and rests, all engineered to encourage colonic contractions.

Who Are The Major Companies Operating In The Constipation Treatment Market?

Major companies operating in the constipation treatment market are Pfizer, Johnson & Johnson, AbbVie, Bayer, Sanofi, Fresenius Kabi, GlaxoSmithKline, Takeda Pharmaceutical Company Ltd, Bausch Health Companies Inc, Salix Pharmaceuticals Inc, Prestige Consumer Healthcare Inc, Ironwood Pharmaceuticals Inc, Cosmo Pharmaceuticals NV, Ferring Pharmaceuticals, Probi AB, 4D Pharma plc, Abbott Laboratories, Albireo Pharma Inc, Ardelyx Inc, Synergy Pharmaceuticals Inc, Astellas Pharma Inc, Allergan plc

Access The Complete Constipation Treatment Market Report:

https://www.thebusinessresearchcompany.com/report/constipation-treatment-global-market-report

What Is The Largest Regional Market In The Constipation Treatment Market?

North America was the largest region in the constipation treatment market in 2025. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the constipation treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Constipation Treatment Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=12134&type=smp

Browse Through More Reports Similar to the Global Constipation Treatment Market 2026, By The Business Research Company

Connected Health And Wellness Solutions Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/connected-health-and-wellness-solutions-global-market-report

Healthcare Services Market 2026

https://www.thebusinessresearchcompany.com/report/healthcare-services-market

Healthcare Services Market 2026

https://www.thebusinessresearchcompany.com/report/healthcare-services-market

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795